Connect with us

Trading Penny Stocks & Using Volume Analysis To Find Stocks To Buy

How to find the most active penny stocks today.
The post Trading Penny Stocks & Using Volume Analysis To Find Stocks To Buy appeared first on Penny…

Published

on

Technical Data and Trading Charts can help determine the right price to sell or buy penny stocks. These penny stock chart patterns are beneficial for traders and investors alike if you know what you’re looking for. Quickly analyzing trading opportunities by watching any changing trends in share prices and trading volumes is critical for identifying entry targets. Today we’ll look more closely at trading volumes as a way to find penny stocks to buy.

Most Active Penny Stocks To Buy

This brings us to today’s focus: identifying potential in the most active penny stocks. The first thing to understand is what “most active” means. We’re referring to penny stocks with much higher or unusually high volume in most cases. This might mean that trading has increased in a particular penny stock and could signal either growing interest in the form of buying or declining interest in the form of heavy selling.

It’s essential to keep a close watch on technical signals and the level of volume in the market. For example, when trading volume decreases during a specific time frame (3-minute chart, for example), that could mean interest is drying up. You might miss this on a daily or hourly chart, but witnessing a trend like this early by paying attention to shorter time frames could help.

What Is A Penny Stock – Definition & More

In this case, the volume drying up could signal that bullish interest has stalled. If that ends up as the case, it could also give a green light for selling pressure in the form of profit-taking or shorting to take the stock lower.

Confirmations & Followthrough

In addition to overall volume, an unusual spike or drop in trading volume might not always indicate or confirm a directional move. For instance, there might be chances that penny stock trading activity shows a bullish spike, and in the next period (depending on chart time frames), it returns to the previous condition. This is where new or inexperienced traders can fall victim to FOMO (Fear Of Missing Out).

Are Penny Stocks Good For Beginners? [Answered]

The quick spike can entice traders to trade emotionally and want to “jump in before it runs.” Unfortunately, they learn a valuable lesson in waiting for follow-through in the stock. This is when an unusual spike in activity is confirmed when additional trading & volume candles continue the aggressive trend.

Basically, the first move (or big spike in volume) isn’t always the right move. A 3-minute candle might be bullish, but if the next few candles on the chart don’t have a similar or greater level of bullish volume, it lacks follow-through. The chances of an uptrend failing are generally higher in this instance.

Penny Stock Trading Volume & What To Look For

So, what can cause a spike in volume?:

  1. There could be an unexpected boom in trading volume due to penny stock news releases
    • Management changes
    • Corporate milestones
    • Oversight body news (FDA, Patents, etc.)
    • Industry presentations
    • Financial news
  2. There is an uptrend happening over a period of time
    • A gradual increase in trading volume could be caused by either rising or falling prices.
    • Industry momentum catalysts
    • Rumors
    • Social media-fueled trading  
  3. There is no ascending or descending movement in Trading Volume
    • Usually means uncertainty in the market
    • Potential bullish and bearish sentiment ahead of news or corporate filings
    • Channel trading can offer day traders opportunities to take advantage of a sideways trend
  4. Sudden decrease due to an unusual event.
    • A sudden dip in trading volume is occasional. This may take place when investors get scared of investing in penny stocks due to things like significant Company issues
    • Similar catalysts as with point #1 but more bearish outcomes than bullish 
  5. There is a downward trend over a period of time
    • This happens when the traders and investors do not take any more interest in a particular penny stock.
    • The market losing faith or a company constantly raising discounted money can be a root cause, among other things 

It’s also important to consider other indicators. Here’s an article to get you informed about different penny stock technical analyses: Technical Strategies To Find Top Penny Stocks.

high volume penny stocks

Making Your List Of High Volume Penny Stocks

It’s not unusual to see high-volume penny stocks within the same industry or sector. Retail traders will often identify one breakout stock and look for sympathy trades. Some of the more prevalent examples of this phenomenon came during the COVID pandemic and at the time when “meme stocks” began to captivate retail traders.

When the pandemic hit, plenty of trends sparked speculative trading action in the stock market. The “Great Toilet Paper Shortage” had traders hunting for paper goods stocks. Even if a company didn’t post news in years, it was a target if their “About” section had any mention of paper. We also saw plenty of vaccine stocks skyrocket. One of the most notable penny stocks, Novavax (NASDAQ: NVAX), went on to explode to highs of more than $300 from price levels below $5 at the onset of the pandemic.

Penny Stocks & Frequently Asked Questions From New Traders

Then we saw meme stocks. Companies like AMC Entertainment (NYSE: AMC), GameStop (NYSE: GME), Bed, Bath, & Beyond (NASDAQ: BBBY), Tilray (NASDAQ: TLRY), and many others took flight. While many had their time to shine, AMC and GME stocks have clearly become the forerunners of this market niche.

The critical thing to remember when making your list of penny stocks with high volume is your strategy. It’s great to see stocks make explosive moves. But if those moves are quicker than you’re prepared for, it could become a losing proposition. For this reason, perfect your trading style and choose high-volume penny stocks that fit your criteria. They don’t always need to be the 1-day movers. There are plenty of high-volume names that trade at consistently heightened levels. That’s something to be aware of when it comes time to putting together your watch list. Just know that this is just the beginning of your research! Check out PennyStocks.com’s Penny Stocks Basics section for more info if you’re new to trading.

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Trading Penny Stocks & Using Volume Analysis To Find Stocks To Buy appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

International

Repeated COVID-19 Vaccination Weakens Immune System: Study

Repeated COVID-19 Vaccination Weakens Immune System: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Repeated COVID-19…

Published

on

Repeated COVID-19 Vaccination Weakens Immune System: Study

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

Repeated COVID-19 vaccination weakens the immune system, potentially making people susceptible to life-threatening conditions such as cancer, according to a new study.

A man is given a COVID-19 vaccine in Chelsea, Mass., on Feb. 16, 2021. (Joseph Prezioso/AFP via Getty Images)

Multiple doses of the Pfizer or Moderna COVID-19 vaccines lead to higher levels of antibodies called IgG4, which can provide a protective effect. But a growing body of evidence indicates that the “abnormally high levels” of the immunoglobulin subclass actually make the immune system more susceptible to the COVID-19 spike protein in the vaccines, researchers said in the paper.

They pointed to experiments performed on mice that found multiple boosters on top of the initial COVID-19 vaccination “significantly decreased” protection against both the Delta and Omicron virus variants and testing that found a spike in IgG4 levels after repeat Pfizer vaccination, suggesting immune exhaustion.

Studies have detected higher levels of IgG4 in people who died with COVID-19 when compared to those who recovered and linked the levels with another known determinant of COVID-19-related mortality, the researchers also noted.

A review of the literature also showed that vaccines against HIV, malaria, and pertussis also induce the production of IgG4.

“In sum, COVID-19 epidemiological studies cited in our work plus the failure of HIV, Malaria, and Pertussis vaccines constitute irrefutable evidence demonstrating that an increase in IgG4 levels impairs immune responses,” Alberto Rubio Casillas, a researcher with the biology laboratory at the University of Guadalajara in Mexico and one of the authors of the new paper, told The Epoch Times via email.

The paper was published by the journal Vaccines in May.

Pfizer and Moderna officials didn’t respond to requests for comment.

Both companies utilize messenger RNA (mRNA) technology in their vaccines.

Dr. Robert Malone, who helped invent the technology, said the paper illustrates why he’s been warning about the negative effects of repeated vaccination.

“I warned that more jabs can result in what’s called high zone tolerance, of which the switch to IgG4 is one of the mechanisms. And now we have data that clearly demonstrate that’s occurring in the case of this as well as some other vaccines,” Malone, who wasn’t involved with the study, told The Epoch Times.

So it’s basically validating that this rush to administer and re-administer without having solid data to back those decisions was highly counterproductive and appears to have resulted in a cohort of people that are actually more susceptible to the disease.”

Possible Problems

The weakened immune systems brought about by repeated vaccination could lead to serious problems, including cancer, the researchers said.

Read more here...

Tyler Durden Sat, 06/03/2023 - 22:30

Read More

Continue Reading

Spread & Containment

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Authored by Jack Phillips via The Epoch Times (emphasis ours),

Twitter…

Published

on

Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked

Authored by Jack Phillips via The Epoch Times (emphasis ours),

Twitter owner Elon Musk invited Democrat presidential candidate Robert F. Kennedy Jr. for a discussion on his Twitter Spaces after Kennedy said his campaign was suspended by Meta-owned Instagram.

Interesting… when we use our TeamKennedy email address to set up @instagram accounts we get an automatic 180-day ban. Can anyone guess why that’s happening?” he wrote on Twitter.

An accompanying image shows that Instagram said it “suspended” his “Team Kennedy” account and that there “are 180 days remaining to disagree” with the company’s decision.

Robert F. Kennedy, Jr. attends Keep it Clean to benefit Waterkeeper Alliance in Los Angeles, Calif., on March 1, 2018. (John Sciulli/Getty Images for Waterkeeper Alliance)

In response to his post, Musk wrote: “Would you like to do a Spaces discussion with me next week?” Kennedy agreed, saying he would do it Monday at 2 p.m. ET.

Hours later, Kennedy wrote that Instagram “still hasn’t reinstated my account, which was banned years ago with more than 900k followers.” He argued that “to silence a major political candidate is profoundly undemocratic.”

“Social media is the modern equivalent of the town square,” the candidate, who is the nephew of former President John F. Kennedy, wrote. “How can democracy function if only some candidates have access to it?”

The Epoch Times approached Instagram for comment.

It’s not the first time that either Facebook or Instagram has taken action against Kennedy. In 2021, Instagram banned him from posting claims about vaccine safety and COVID-19.

After he was banned by the platform, Kennedy said that his Instagram posts raised legitimate concerns about vaccines and were backed by research. His account was banned just days after Facebook and Instagram announced they would block the spread of what they described as misinformation about vaccines, including research saying the shots cause autism, are dangerous, or are ineffective.

“This kind of censorship is counterproductive if our objective is a safe and effective vaccine supply,” he said at the time.

Read more here...

Tyler Durden Sat, 06/03/2023 - 20:30

Read More

Continue Reading

International

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Authored by Jessie Zhang via Thje Epoch…

Published

on

Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction

Authored by Jessie Zhang via Thje Epoch Times (emphasis ours),

An Australian and Swedish investigation has found that among the hundreds of COVID-19 research papers that have been withdrawn, a retracted study linking the drug hydroxychloroquine to increased mortality was the most cited paper.

Hydroxychloroquine sulphate tablets. (Memories Over Mocha/Shutterstock)

With 1,360 citations at the time of data extraction, researchers in the field were still referring to the paper “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” long after it was retracted.

Authors of the analysis involving the University of Wollongong, Linköping University, and Western Sydney Local Health District wrote (pdf) that “most researchers who cite retracted research do not identify that the paper is retracted, even when submitting long after the paper has been withdrawn.”

“This has serious implications for the reliability of published research and the academic literature, which need to be addressed,” they said.

Retraction is the final safeguard against academic error and misconduct, and thus a cornerstone of the entire process of knowledge generation.”

Scientists Question Findings

Over 100 medical professionals wrote an open letter, raising ten major issues with the paper.

These included the fact that there was “no ethics review” and “unusually small reported variances in baseline variables, interventions and outcomes,” as well as “no mention of the countries or hospitals that contributed to the data source and no acknowledgments to their contributions.”

A bottle of Hydroxychloroquine at the Medicine Shoppe in Wilkes-Barre, Pa on March 31, 2020. Some politicians and doctors were sparring over whether to use hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it yet. (Mark Moran/The Citizens’ Voice via AP)

Other concerns were that the average daily doses of hydroxychloroquine were higher than the FDA-recommended amounts, which would present skewed results.

They also found that the data that was reportedly from Australian patients did not seem to match data from the Australian government.

Eventually, the study led the World Health Organization to temporarily suspend the trial of hydroxychloroquine on COVID-19 patients and to the UK regulatory body, MHRA, requesting the temporary pause of recruitment into all hydroxychloroquine trials in the UK.

France also changed its national recommendation of the drug in COVID-19 treatments and halted all trials.

Currently, a total of 337 research papers on COVID-19 have been retracted, according to Retraction Watch.

Further retractions are expected as the investigation of proceeds.

Tyler Durden Sat, 06/03/2023 - 17:30

Read More

Continue Reading

Trending